Tumor-induced Osteomalacia in a Boy with Maxillary Ossifying Fibroma
PDF

Case Report

Tumor-induced Osteomalacia in a Boy with Maxillary Ossifying Fibroma

J Clin Res Pediatr Endocrinol 2023;15(4):421-425 DOI: 10.4274/jcrpe.galenos.2022.2021-8-14
, , , , ,
PDF
Permissions

Abstract

Tumor-induced osteomalacia (TIO) is a rare, paraneoplastic disorder of hypophosphatemia associated with elevated tumor-produced fibroblast growth factor 23 (FGF23). Maxillofacial tumors are rarely involved in TIO, especially maxillary TIO in children. We present a 14-year-old boy with osteomalacia and high serum levels of FGF23, a hormone associated with decreased phosphate resorption, due to a maxillary tumor. The patient was treated with oral phosphorus and calcitriol, and surgical removal of the tumor was performed. After 21 months follow-up, he was pain free and had returned to full activity. We review the reported pediatric cases of TIO in the maxillofacial and oral region and discuss the management of these patients considering the published evidence.

Keywords: Tumor-induced osteomalacia, fibroblast growth factor-23, maxilla, children

Read the full text

3 sections · PDF

Create your free account to read the full text.

  • Full text with figures and tables
  • PDF and supplementary files
  • Access on every Galenos journal
Get free access

Already have an account?

Sign in
or
Continue with Google

One Galenos account works on every Galenos journal site.